European Respiratory Journal

The ERJ publishes clinical and experimental work relating to all aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine and thoracic surgery. In addition to original research material, the ERJ also publishes editorial commentaries, reviews, short research letters and correspondence to the editor. Articles are published continuously and collected into 12 monthly issues in two volumes per year.

August

ERJ August Podcast: management of chronic thromboembolic pulmonary hypertension Eur Respir J 2016; 48: E68
Which CD8+ T-cells in asthma? Attacking or defending? Baraldo Simonetta, Turato Graziella, Cosio Manuel G., Saetta Marina Eur Respir J 2016; 48: 287-290
Metabolic consequences of obesity as an “outside in” mechanism of disease severity in asthma Peters Michael C., Fahy John V. Eur Respir J 2016; 48: 291-293
Complex lung function in severe asthma: seeing is believing King Gregory G., Thamrin Cindy Eur Respir J 2016; 48: 294-296
Primary ciliary dyskinesia: the patients grow up Kuehni Claudia E., Goutaki Myrofora, Carroll Mary, Lucas Jane S. Eur Respir J 2016; 48: 297-300
Interleukin-1alpha: a key player for epithelial-to-mesenchymal signalling in COPD? Froidure Antoine, Ladjemi Maha Zohra, Pilette Charles Eur Respir J 2016; 48: 301-304
Pulmonary arterial hypertension and the Enigma code of smouldering inflammation Gomez-Arroyo Jose, Abbate Antonio, Voelkel Norbert F. Eur Respir J 2016; 48: 305-307
The difficult diagnosis of pulmonary vascular disease in heart failure Naeije Robert, Hemnes Anna Ryan Eur Respir J 2016; 48: 308-310
The difficult diagnosis of pulmonary vascular disease in heart failure Galiè Nazzareno, Manes Alessandra, Palazzini Massimiliano Eur Respir J 2016; 48: 311-314
Should we use gait speed in COPD, FEV1 in frailty and dyspnoea in both? Bousquet Jean, Dinh-Xuan Anh Tuan, Similowski Thomas, Malva João, Ankri Joël, Barbagallo Mario, Fabbri Leonardo, Humbert Marc, Mercier Jacques, Robalo-Cordeiro Carlos, Rodriguez-Manas Leocadio, Vellas Bruno Eur Respir J 2016; 48: 315-319
A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol Pascoe Steven J., Lipson David A., Locantore Nicholas, Barnacle Helen, Brealey Noushin, Mohindra Rajat, Dransfield Mark T., Pavord Ian, Barnes Neil Eur Respir J 2016; 48: 320-330
Thoracic dust exposure is associated with lung function decline in cement production workers Nordby Karl-Christian, Notø Hilde, Eduard Wijnand, Skogstad Marit, Fell Anne Kristin, Thomassen Yngvar, Skare Øivind, Bergamaschi Antonio, Pietroiusti Antonio, Abderhalden Rolf, Kongerud Johny, Kjuus Helge Eur Respir J 2016; 48: 331-339
Physical activity and exercise capacity in patients with moderate COPD exacerbations Alahmari Ayedh D., Kowlessar Beverly S., Patel Anant R.C., Mackay Alex J., Allinson James P., Wedzicha Jadwiga A., Donaldson Gavin C. Eur Respir J 2016; 48: 340-349
Accelerated telomere attrition in children and teenagers with alpha1-antitrypsin deficiency Escribano Amparo, Pastor Sara, Reula Ana, Castillo Silvia, Vicente Silvia, Sanz Francisco, Casas Francisco, Torres María, Fernández-Fabrellas Estrella, Codoñer-Franch Pilar, Dasí Francisco Eur Respir J 2016; 48: 350-358
Interleukin-1alpha drives the dysfunctional cross-talk of the airway epithelium and lung fibroblasts in COPD Osei Emmanuel T., Noordhoek Jacobien A., Hackett Tillie L., Spanjer Anita I.R., Postma Dirkje S., Timens Wim, Brandsma Corry-Anke, Heijink Irene H. Eur Respir J 2016; 48: 359-369
Is ventilation heterogeneity related to asthma control? Svenningsen Sarah, Nair Parameswaran, Guo Fumin, McCormack David G., Parraga Grace Eur Respir J 2016; 48: 370-379
Neuro-immune interactions in chemical-induced airway hyperreactivity Devos Fien C., Boonen Brett, Alpizar Yeranddy A., Maes Tania, Hox Valérie, Seys Sven, Pollaris Lore, Liston Adrian, Nemery Benoit, Talavera Karel, Hoet Peter H.M., Vanoirbeek Jeroen A.J. Eur Respir J 2016; 48: 380-392
Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells den Otter Irene, Willems Luuk N.A., van Schadewijk Annemarie, van Wijngaarden Simone, Janssen Kirsten, de Jeu Ronald C., Sont Jacob K., Sterk Peter J., Hiemstra Pieter S. Eur Respir J 2016; 48: 393-402
Insulin resistance modifies the association between obesity and current asthma in adults Cardet Juan Carlos, Ash Samuel, Kusa Tope, Camargo Carlos A., Israel Elliot Eur Respir J 2016; 48: 403-410
Natural variability of lung function in young healthy school children Kirkby Jane, Bountziouka Vassiliki, Lum Sooky, Wade Angie, Stocks Janet Eur Respir J 2016; 48: 411-419
Utility of measuring FEV0.75/FVC ratio in preschoolers with uncontrolled wheezing disorder Nève Véronique, Hulo Sébastien, Edmé Jean-Louis, Boileau Sophie, Baquet Georges, Pouessel Guillaume, Thumerelle Caroline, Deschildre Antoine, Matran Régis Eur Respir J 2016; 48: 420-427
Physical activity is not associated with spirometric indices in lung-healthy German youth Smith Maia P., von Berg Andrea, Berdel Dietrich, Bauer Carl-Peter, Hoffmann Barbara, Koletzko Sibylle, Nowak Dennis, Heinrich Joachim, Schulz Holger Eur Respir J 2016; 48: 428-440
A longitudinal study characterising a large adult primary ciliary dyskinesia population Shah Anand, Shoemark Amelia, MacNeill Stephanie J., Bhaludin Basrull, Rogers Andrew, Bilton Diana, Hansell David M., Wilson Robert, Loebinger Michael R. Eur Respir J 2016; 48: 441-450
Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids Dekkers Johanna F., Gogorza Gondra Ricardo A., Kruisselbrink Evelien, Vonk Annelotte M., Janssens Hettie M., de Winter-de Groot Karin M., van der Ent Cornelis K., Beekman Jeffrey M. Eur Respir J 2016; 48: 451-458
CD133+ cells in pulmonary arterial hypertension Foris Vasile, Kovacs Gabor, Marsh Leigh M., Bálint Zoltán, Tötsch Martin, Avian Alexander, Douschan Philipp, Ghanim Bahil, Klepetko Walter, Olschewski Andrea, Olschewski Horst Eur Respir J 2016; 48: 459-469
Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension Parpaleix Aurélien, Amsellem Valérie, Houssaini Amal, Abid Shariq, Breau Marielle, Marcos Elisabeth, Sawaki Daigo, Delcroix Marion, Quarck Rozenn, Maillard Aurélie, Couillin Isabelle, Ryffel Bernhard, Adnot Serge Eur Respir J 2016; 48: 470-483
Expanded lung T-bet+RORyT+ CD4+ T-cells in sarcoidosis patients with a favourable disease phenotype Kaiser Ylva, Lepzien Rico, Kullberg Susanna, Eklund Anders, Smed-Sörensen Anna, Grunewald Johan Eur Respir J 2016; 48: 484-494
Risk factors for short-term outcomes after thoracoscopic lobectomy for lung cancer Irie Masataka, Nakanishi Ryoichi, Yasuda Manabu, Fujino Yoshihisa, Hamada Kazumi, Hyodo Masahiro Eur Respir J 2016; 48: 495-503
Cigarette smoke-induced epithelial expression of WNT-5B: implications for COPD Heijink Irene H., de Bruin Harold G., Dennebos Robin, Jonker Marnix R., Noordhoek Jacobien A., Brandsma Corry-Anke, van den Berge Maarten, Postma Dirkje S. Eur Respir J 2016; 48: 504-515
Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? Albert Heidi, Nathavitharana Ruvandhi R., Isaacs Chris, Pai Madhukar, Denkinger Claudia M., Boehme Catharina C. Eur Respir J 2016; 48: 516-525
Quality of life in patients with chronic thromboembolic pulmonary hypertension Mathai Stephen C., Ghofrani Hossein-Ardeschir, Mayer Eckhard, Pepke-Zaba Joanna, Nikkho Sylvia, Simonneau Gérald Eur Respir J 2016; 48: 526-537
Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis Selman Moisés, López-Otín Carlos, Pardo Annie Eur Respir J 2016; 48: 538-552
How to define pulmonary hypertension due to left heart disease Gerges Mario, Gerges Christian, Lang Irene M. Eur Respir J 2016; 48: 553-555
A retrospective cohort study of patients with pulmonary embolism: the impact of comorbidities on patient's outcome Mameli Antonella, Palmas Maria Antonietta, Antonelli Antonello, Contu Paolo, Prandoni Paolo, Marongiu Francesco Eur Respir J 2016; 48: 555-557
Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids Ducharme Francine M., Gagnon Roxanne, Bénard Brigitte, Tse Sze Man, Thivierge Robert Eur Respir J 2016; 48: 558-560
Factors associated with undiagnosed and overdiagnosed COPD Gershon Andrea S., Hwee Jeremiah, Chapman Kenneth R., Aaron Shawn D., O'Donnell Denis E., Stanbrook Matthew B., Bourbeau Jean, Tan Wan, Su Jiandong, Victor J. Charles, To Teresa Eur Respir J 2016; 48: 561-564
Handling missing items in the Exacerbations of Chronic Pulmonary Disease Tool Hitchings Andrew W., Baker Emma H., Jones Paul W. Eur Respir J 2016; 48: 564-566
Interval training induces clinically meaningful effects in daily activity levels in COPD Louvaris Zafeiris, Spetsioti Stavroula, Kortianou Eleni A., Vasilopoulou Maroula, Nasis Ioannis, Kaltsakas Georgios, Koulouris Nikolaos G., Vogiatzis Ioannis Eur Respir J 2016; 48: 567-570
Silent aspiration in patients with exacerbation of COPD Zheng Zeguang, Wu Zhida, Liu Ni, Chen Ping, Hou Peng, Wang Xinni, Fu Yimin, Liang Weijian, Chen Rongchang Eur Respir J 2016; 48: 570-573
Susceptibility genes for lung diseases in the major histocompatibility complex revealed by lung expression quantitative trait loci analysis Lamontagne Maxime, Joubert Philippe, Timens Wim, Postma Dirkje S., Hao Ke, Nickle David, Sin Don D., Pare Peter D., Laviolette Michel, Bossé Yohan Eur Respir J 2016; 48: 573-576
Hydrogen cyanide emission in the lung by Staphylococcus aureus Neerincx Anne H., Linders Ylona A.M., Vermeulen Laura, Belderbos Robert A., Mandon Julien, van Mastrigt Esther, Pijnenburg Marielle W., van Ingen Jakko, Mouton Johan W., Kluijtmans Leo A.J., Wevers Ron A., Harren Frans J.M., Cristescu Simona M., Merkus Peter J.F.M. Eur Respir J 2016; 48: 577-579
Pouched rats as detectors of tuberculosis: comparison to concentrated smear microscopy Edwards Timothy L., Valverde Emilio, Mulder Christiaan, Cox Christophe, Poling Alan Eur Respir J 2016; 48: 579-582
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis? Guglielmetti Lorenzo, Le Dû Damien, Veziris Nicolas, Caumes Eric, Marigot-Outtandy Dhiba, Yazdanpanah Yazdan, Robert Jérôme, Fréchet-Jachym Mathilde Eur Respir J 2016; 48: 582-585
Respiratory decline is integral to disease progression in Huntington's disease Jones Una, Busse Monica, Enright Stephanie, Rosser Anne E. Eur Respir J 2016; 48: 585-588
Increased use of high-flow nasal oxygen during bronchoscopy Santos Pedro Silva, Cruz Cristiana, Esquinas Antonio M. Eur Respir J 2016; 48: 589
Increased use of high-flow nasal oxygen during bronchoscopy La Combe Beatrice, Messika Jonathan, Fartoukh Muriel, Ricard Jean-Damien Eur Respir J 2016; 48: 590-592
“Cortical drive to breathe in amyotrophic lateral sclerosis: a dyspnoea-worsening defence?” Marjolaine Georges, Elise Morawiec, Mathieu Raux, Jésus Gonzalez-Bermejo, Pierre-François Pradat, Thomas Similowski and Capucine Morélot-Panzini. Eur Respir J 2016; 47: 1818–1828. Eur Respir J 2016; 48: 593
“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784. Eur Respir J 2016; 48: 593